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Although experimental studies have suggested that a high arterial oxygen pressure (PaO2) might aggravate
post-anoxic brain injury, clinical studies in patients resuscitated from cardiac arrest (CA) have given conflicting
results. Some studies found that a PaO2 of more than 300 mm Hg (hyperoxemia) was an independent predictor of
poor outcome, but others reported no association between blood oxygenation and neurological recovery in this
setting. In this article, we review the potential mechanisms of oxygen toxicity after CA, animal data available in this
field, and key human studies dealing with the impact of oxygen management in CA patients, highlighting some
potential confounders and limitations and indicating future areas of research in this field. From the currently available
literature, high oxygen concentrations during cardiopulmonary resuscitation seem preferable, whereas hyperoxemia
should be avoided in the post-CA care. A specific threshold for oxygen toxicity has not yet been identified. The
mechanisms of oxygen toxicity after CA, such as seizure development, reactive oxygen species production, and the
development of organ dysfunction, need to be further evaluated in prospective studies.Introduction
Sudden cardiac arrest (CA) is the leading cause of death
among adults worldwide [1,2]. In most patients, attempts
at cardiopulmonary resuscitation (CPR) remain ineffective
and spontaneous cardiac activity cannot be restored [3].
Among those patients who do achieve return of spontan-
eous circulation (ROSC), there are two key periods when
death may occur: early (during the first three days), usually
because of recurrent CA or severe cardiovascular failure
resulting in multiple organ failure (MOF), and late (beyond
day 3), usually secondary to withdrawal of life-sustaining
therapies in the absence of neurological recovery [4]. Al-
though several interventions, including target temperature
management (TTM), have been introduced into the post-
CA care of these patients [5,6], conflicting results have been
obtained [7], and these approaches are not sufficient to pre-
vent the deleterious consequences of brain ischemia in all
patients. During the post-CA care, secondary brain insult
must be avoided [8] and optimization of brain oxygenation
is likely to be an important component of brain recovery.
The restoration of adequate systemic hemodynamics is a
prerequisite to provide adequate cerebral blood flow in CA
patients [9,10], but brain oxygenation is also determined by* Correspondence: ftaccone@ulb.ac.be
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(PaO2) itself may influence brain cellular oxygen supply;
if hypoxemia (that is, PaO2 of less than 60 mm Hg) is asso-
ciated with poor outcomes after CA [11], a high PaO2 may
also be detrimental in a vulnerable brain, as suggested in
patients with traumatic brain injury or stroke [12,13]. The
aims of this article are to review the potential mechanisms
of oxygen toxicity after CA and to discuss the clinical
impact of oxygen management on post-CA care.Post-cardiac arrest syndrome: the role of oxygen
Post-cardiac arrest syndrome (PCAS) is a complex
phenomenon, which shares several features with septic
shock [7,14]. In particular, PCAS includes a systemic
inflammatory response that can be triggered by the is-
chemia-reperfusion injury and also specific precipitating
events, such as concomitant infections or heart disease.
Moreover, PCAS can contribute to brain injury and
myocardial dysfunction and can rapidly lead to MOF.
The primary ischemia-reperfusion injury [15] activates
various intracellular pathways, promoting ion concentra-
tion disequilibrium with increased intracellular levels of
inorganic phosphate, lactate, and H+, and resulting in an
influx of calcium into the cell [16], which aggravates
mitochondrial dysfunction and eventually leads to pro-
grammed cellular death (apoptosis). After reperfusion hasral Ltd. The licensee has exclusive rights to distribute this article, in any medium, for
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−),
peroxynitrite (NO2
−), hydrogen peroxide (H2O2), and hy-
droxyl radicals (OH−), contribute to worsen cellular function
by oxidizing and damaging numerous cellular components
[17] (Figure 1). These reactive oxygen species (ROS)
then have a central role in initiating and enhancing the
post-ischemic damage [15]. Indeed, supra-normal oxygen
concentrations in this context may further stimulate ROS
production and contribute to worsen cellular function in a
setting of impaired mitochondrial function and impaired
oxygen utilization. Moreover, some other systemic detri-
mental effects of hyperoxemia have been known for many
years [18-20]. Hyperoxemia causes systemic and coronary
vasoconstriction, which can decrease cardiac output and
induce myocardial ischemia. In some experimental models
of global cerebral ischemia, hyperoxemia has been shown
to be detrimental to the brain, probably also because of
its vasoconstrictor effects [21,22]. Hyperoxemia may
also provoke or exacerbate seizures, which could aggra-
vate brain injury [23,24].
Oxygen therapy after cardiac arrest: animal studies
Several studies have assessed the effects of administering
high oxygen concentrations in experimental models of
CA. Pilcher and colleagues [25] recently reviewed studies
that evaluated the role of different oxygenation strategies -
that is, one with 100% inspired oxygen fraction (FiO2) and
the other with lower FiO2 as a control - after ROSC. Six
studies including 95 animals of different species were in-
cluded in their final meta-analysis; in general, administrationFigure 1 Summary of cellular and systemic effects of high oxygen (O
oxide; NOS, nitric oxide synthase; O2
• −, superoxide ion; •OH, hydroxide ion;of high FiO2 (100%) for 1 hour after ROSC resulted in a
worse neurological outcome, as assessed by a neurological
deficit score, than other FiO2 values. Four of the five studies
that assessed histological damage reported a significantly
higher neuronal injury with high FiO2; cerebral metabolic
function was also more altered in the high FiO2 group. The
extrapolation of such findings to humans, however, may be
misleading. First, in all of these experimental studies, the an-
imals were already mechanically ventilated before CA, and
this is not usually the case in humans; also, control animals
did not all receive the same FiO2 (ranging from 21% to
higher levels based on PaO2 values), and the intervention
period was rather short (that is, 1 hour). Moreover, differ-
ent models of CA were employed (that is, asphyxia versus
electrical-induced ventricular fibrillation), with shorter du-
rations of CPR than in humans, and in some articles clear
PaO2 targets were aimed at, whereas in others only FiO2
was modified without looking at PaO2 values. In addition,
no potential neuroprotective therapy, such as TTM, was
provided, so that its influence cannot be ascertained. In
summary, animal data have highlighted a clear correlation
between the application of high FiO2 after CA and poor
neurological recovery. Nevertheless, experimental models
are quite remote from the human setting, so that the ob-
servations cannot be readily translated to humans in the
post-CA management.
Oxygen after cardiac arrest: human studies
Two studies reported conflicting results regarding oxy-
gen management during the early phase of CA (Table 1).2) concentrations. H2O, water; H2O2, hydrogen peroxide; NO, nitric
ONOO−, peroxynitrite ion.
Table 1 Summary of clinical studies evaluating the role of oxygen concentrations on outcome after cardiac arrest
Reference Type Patients (period)% of HO OHCA Definition HO Evaluation TH (% treated) Cutoffa Outcome Main results
During CPR
Spindelboeck et al. [26] R 145 (8 years) 14% 100% >300 mm Hg During
CPR
NA NR In-hospital CPC Higher rate of hospital admission
in hyperoxemic patients
After ROSC




No (50%) No NSE and S100B No difference in biomarkers of
brain injury
Post-CA care (ICU stay)




Kilgannon et al. [29] R/D 4,459 (5 years) 18% 45% First ABG 24-hour NR ≈ 6% No In-hospital death Increased hospital mortality for




Bellomo et al. [31] R/D 12,108 (10 years) 11% 68% Worst (A-a) ΔO2 > 300 mm Hg 24-hour NR ≈ 33% No In-hospital death
b Hyperoxemia did not affect
outcome when adjusted for
several confounders.
Janz et al. [32] R 170 (5 years) ≈ 25% 80% Highest PaO2 24-hour Yes No In-hospital death Increased hospital mortality for
every 100 mm Hg increase
in PaO2
In-hospital CPC
Ihle et al. [33] R 584 (5 years) ≈ 6% 100% Worst (A-a) ΔO2 > 300 mm Hg 24-hour NR No In-hospital death Hyperoxemia did not affect outcome.
Lee et al. [34] R 213 (4 years) <3% 83% Mean PaO2 value 24-hour Yes No In-hospital death V-shaped association between
the mean PaO2 and poor
neurologic outcome at hospital
discharge
Vaahersalo et al. [35] P 409 (1 year) 100% Mean PaO2 value >300 mm Hg 24-hour Yes (71%) No 1-year CPC PaO2 was not correlated to
outcome
aIdentification of an arterial oxygen pressure (PaO2) threshold to accurately separate patients with good and poor outcome.
bAfter adjustment on Acute Physiology and Chronic Health Evaluation III (APACHE III) score.
(A-a)ΔO2, alveolo-arterial oxygen difference; ABG, arterial blood gas (analysis); CA, cardiac arrest; CPC, Cerebral Performance Category; CPR, cardiopulmonary resuscitation; FiO2, inspired oxygen fraction; HO, hyperoxemia;
NA, not available; NR, not reported; NSE, neuron-specific enolase; OHCA, out-of-hospital cardiac arrest; P, prospective; R, retrospective; RCT, randomized clinical trial; R/D, retrospective analysis of database; ROSC, return of
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colleagues [26] observed that high PaO2 (more than
300 mm Hg) levels during CPR were associated with
higher rates of ROSC and intact neurological survival
when compared with low (PaO2 of less than 60 mm Hg)
and normal PaO2. In contrast, Kuisma and colleagues [27]
randomly assigned 28 patients to receive either 30% or
100% FiO2 for 1 hour after ROSC; five patients (36%) in the
group with lower FiO2 required an increase in FiO2 to 40%
because oxygen saturation fell below 95%, according to a
standardized protocol. The primary endpoints were bio-
marker levels of brain injury - that is, neuron-specific eno-
lase (NSE) and S100B - at 24 and 48 hours after ROSC,
with no differences in absolute values between the two
groups overall. However, in the subgroup of patients who
did not undergo TTM, those receiving lower FiO2 had
lower NSE levels at 24 hours than the other patients (7.6 ±
4.2 versus 13.5 ± 9.6 μg/mL, P = 0.049). Thus, one may
argue that high PaO2 during CPR reflects better lung func-
tion or better quality CPR or both, with higher blood flow
and better tissue oxygenation (indeed all patients received
FiO2 of 100%), whereas administration of high FiO2 imme-
diately after ROSC could enhance brain injury. Importantly,
the retrospective nature of the study by Spindelboeck and
colleagues [26] may have limited the analysis of all factors
possibly affecting outcome (that is, quality of CPR, comor-
bidities, and so on). Also, blood gas analysis samples were
drawn within 60 minutes from CPR initiation, and it is dif-
ficult to compare patients analyzed in the early CPR with
those included in the later phase, who may have developed
pulmonary injury with reduced PaO2 due to prolonged
resuscitation itself. It is difficult to determine the role of
oxygen levels during CPR per se on neurological outcome
of CA patients because they may be a surrogate marker of
resuscitation performance or better cardiorespiratory status
or both. Moreover, brain injury is a continuous process,
and the time course of PaO2 may more significantly influ-
ence neurological outcome in these patients.
Few clinical studies have evaluated the role of hyperoxe-
mia during the ICU stay on outcome of CA patients.
Kilgannon and colleagues published two different analyses
on the same large database from a cohort of patients from
131 US hospitals (Increase Minority Participation and
Awareness of Clinical Trials (IMPACT) Database). In the
first study [28], including 6,326 patients, hospital mortality
was higher in patients with hypoxemia (defined as a PaO2
of less than 60 mm Hg or altered gas exchange with a
PaO2/FiO2 ratio of less than 300) or hyperoxemia (PaO2
of more than 300 mm Hg) detected in the first arterial
blood gas (ABG) available within 24 hours after admission,
compared with patients with normal oxygen levels (hyp-
oxemia 53% versus hyperoxemia 67% versus normoxemia
45%, P < 0.001). In a multivariable logistic regression
analysis, hyperoxemia was independently associated within-hospital mortality: odds ratio (OR) 1.8, 95% confidence
interval (CI) 1.5 to 2.2. In the second study, after exclusion
of patients with hypoxemia, the investigators wanted to
evaluate the association between PaO2, considered as a
continuous variable, and in-hospital mortality [29]. In the
4,459 patients studied, the median PaO2 was 231 (inter-
quartile range 149 to 349) mm Hg and in-hospital mortal-
ity was 54%. Multivariable analysis yielded a significant 6%
increase in mortality for any PaO2 increase by 25 mm Hg
(OR 1.06, 95% CI 1.05 to 1.07). Although these two studies
support the hypothesis that hyperoxemia is associated with
worse outcome after CA, some limitations must be ac-
knowledged. First, only a small proportion of patients were
treated with hypothermia. Second, the use of the PaO2/
FiO2 ratio does not really reflect hypoxemia, because it is a
surrogate of lung failure rather than of low arterial oxygen
content. Third, data were not collected following the
Utstein style [30] or corrected for severity of disease (for
example, Acute Physiology and Chronic Health Evaluation
III, or APACHE III). Finally, and even more importantly,
only the first ABG was taken into account in the final ana-
lysis instead of a mean value over the first 24 hours, which
might be more representative of real oxygen exposure dur-
ing this crucial period.
In a large Australian database (Australian and New
Zealand Intensive Care Society-Adult Patient Database,
or ANZICS-APD), Bellomo and colleagues [31] evaluated
the correlation between different PaO2 levels and hospital
mortality in 12,108 patients. Although these authors used
the same definitions of hypoxemia and hyperoxemia used
in previous studies [28,29], they reported a lower percent-
age of patients with hyperoxemia (11% [31] versus 18%
[28]) but still a higher mortality rate for patients with
hyperoxemia (59%) and hypoxemia (60%) when compared
with normoxic patients (47%). In a multivariable model
including some major confounding factors, hyperoxemia
was significantly associated with mortality (OR 1.2, 95%
CI 1.1 to 1.6); however, in a Cox proportional hazards
regression model, after adjustment for other relevant co-
variates (year of admission, treatment limitations, patient’s
lowest glucose level in the first 24 hours, patient’s indigen-
ous status, and hospital source from home), PaO2 was no
longer statistically associated with poor outcome (hazard
ratio 1.1, 95% CI 1.0 to 1.2; P = 0.20). Despite the limita-
tion of a retrospective analysis, this study highlights that
some confounders not taken into account in previous
studies may have influenced the statistical association be-
tween high PaO2 and poor outcome. Importantly, other
issues may further limit the power of these findings. The
PaO2 from the ABG analysis associated with the worst
alveolo-arterial oxygen difference was used, and this PaO2
correlated only fairly with the mean PaO2 (as shown in
the analysis of a subgroup of patients) and may not have
adequately reflected the exposure of patients to high
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gested by the lower PaO2 values recorded in this study
when compared with previous publications (112 versus
231 mm Hg) [29]. Also, no data on neurological outcomes
were reported. Finally, as in previous studies, only a mi-
nority of patients underwent hypothermia, but cooling is
considered to mitigate ROS production and possibly influ-
ence hyperoxemia-mediated brain injury [8].
The first article to include patients treated with hypo-
thermia [32] showed that those with a poor outcome had
higher PaO2 values than others (254 versus 198 mm Hg;
P = 0.022). A multivariable regression model, including
factors known to be associated with poor outcome after
CA, confirmed an independent correlation of PaO2 with
mortality (OR for a PaO2 increment of every 100 mm Hg
above 54 mm Hg 1.48, 95% CI 1.03 to 2.01) and worse
neurological outcome (OR 1.48, 95% CI 1.03 to 2.14) at
hospital discharge; however, neither FiO2 nor APACHE III
score was included in the final analysis. Unfortunately, no
specific cutoff of PaO2 was identified to predict poor
outcome, although a PaO2 of more than 228 mm Hg was
associated with a lower likelihood of neurological recov-
ery. More recently, Ihle and colleagues [33] reviewed 584
patients selected from the ANZICS-APD database, for
whom variables could be found following the Utstein
model [30]. Unadjusted in-hospital mortality did not differ
across different PaO2 ranges (51% hypoxia, 41% normoxia,
and 47% hyperoxia; P = 0.28). In a multivariable model
including CA characteristics, neither hypoxemia nor hy-
peroxemia was an independent predictor of in-hospital
mortality. In a retrospective cohort of 213 adult patients
with CA, Lee and colleagues [34] reported that PaO2
obtained during the first 24 hours was not related to hos-
pital mortality or neurological outcome. In a multivariable
model adjusted for established confounding factors after
CA, the authors showed a V-shaped relationship between
PaO2 and neurological outcome, with the highest prob-
ability of good neurologic outcome at PaO2 around
130 mm Hg. Finally, in a prospective observational study
(n = 409), Vaahersalo and colleagues [35] calculated the
proportion of time spent in different oxygen categories
(less than 75 mm Hg, 75 to 150 mm Hg, 150 to 225 mm
Hg, and more than 225 mm Hg) during the first 24 hours
after CA. The proportion of time spent with a PaO2 of
more than 225 mm Hg was similar between groups, as
was the association of time within different PaO2 cate-
gories and outcome. Mean and highest PaO2 values
were higher in patients with good neurological out-
come than in those with poor neurological outcome
(120 versus 113 mm Hg and 173 versus 150 mm Hg,
respectively). Interestingly, the proportion of patients
with good neurological outcome was higher in pa-
tients with the combination of high mean PaO2 and
PaCO2 values.Perspectives and conclusions
The International Liaison Committee on Resuscitation
states that oxygen administration should be titrated to
obtain an oxygen saturation of 94% to 96% after ROSC
[36]. Thus, routine administration of an FiO2 of 100% is
no longer recommended after CPR [36,37]; however, it
still seems prudent to use 100% oxygen during CPR,
although the impact of high PaO2 on survival needs to
be further evaluated. Although some studies have sug-
gested that hyperoxemia after CA should be considered
a cost-free, potentially modifiable risk factor for poor out-
come, many potential confounders have been identified
and strongly challenge this concept. Moreover, it is very
difficult to identify a specific threshold of toxicity, as most
of the studies used a PaO2 of more than 300 mm Hg to
define hyperoxemia, while some brain injury may also
potentially occur at lower values. Also, when a single ABG
value was used, the proportion of patients with hypero-
xemia ranged from 3% to 25% in the different studies
[27-29,31-34]. Nevertheless, when all ABG values are con-
sidered, the incidence of hyperoxemia may exceed 40%
[38], so that the real impact of exposure to high oxygen
concentrations has probably been underestimated. Other
parameters obtained from the ABG, such as acidemia or
hypocapnia, may also be important determinants of poor
outcome after CA [39,40]; however, these variables were
not considered in these studies. Importantly, it is worth-
while to prospectively evaluate the mechanisms of oxygen
toxicity after CA, such as seizure development, ROS pro-
duction, impaired microcirculation, or the development of
organ dysfunction. Finally, further studies are needed to
help understand whether an absolute PaO2 value (that is,
‘peak’) could be more detrimental than a continuous
exposure above a specific threshold and to assess the im-
pact of the timing of hyperoxemia occurrence (early versus
late phase after arrest) or of variability in oxygen levels
(that is, from hypoxemia to hyperoxemia) in this setting.
Key messages
 Hyperoxemia may potentially exacerbate or
aggravate brain injury after experimental
cardiac arrest.
 Hyperoxemia has been associated with
controversial results in humans.
 Administering high FiO2 (100%) during
CPR still seems to be advisable because it may
facilitate ROSC.
 Because of the limited benefit of maintaining
potentially harmful supra-normal oxygen
levels in such patients, mechanical ventilation
should be titrated to maintain an oxygen
saturation between 94% and 96% in most
patients after ROSC.
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